Prevalence Of Keratoconus Among Patients With Thyroid Gland Dysfunction
1 other identifier
observational
400
1 country
1
Brief Summary
Hormonal imbalances are likely to affect the corneal metabolism and may be also associated with Keratoconus. Among the various endocrinologic dysfunctions assumed so far, thyroid gland dysfunction (TGD) (hypo- or hyperthyroidism; comprised as TGD) is frequently associated with eye diseases such as Graves disease
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2020
CompletedStudy Start
First participant enrolled
April 12, 2020
CompletedFirst Posted
Study publicly available on registry
April 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2022
CompletedSeptember 8, 2022
September 1, 2022
1.9 years
April 12, 2020
September 2, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
prevalence of keratoconus in thyroid gland dysfunction
Our Screening for KC will include evaluation of the demographic data and complete ophthalmological examination of the patients using: VA Refraction K reading Slit lamp examination Pentacam
we will recruit patients who meer the inclusion criteria during the study period April-August 2020
Interventions
no intervention
Eligibility Criteria
we will enroll all patients who meet the inclusion criteria and signed a written informed consent form
You may qualify if:
- All patients diagnosed as thyroid gland dysfunction
You may not qualify if:
- Uncooperative patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fayoum University
Al Fayyum, 63514, Egypt
Biospecimen
blood sample to measure thyroid profile
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
April 12, 2020
First Posted
April 15, 2020
Study Start
April 12, 2020
Primary Completion
March 15, 2022
Study Completion
March 15, 2022
Last Updated
September 8, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share